148
Participants
Start Date
March 31, 2009
Primary Completion Date
April 30, 2010
Study Completion Date
June 30, 2010
AST-120
AST-120
Weill Medical College of Cornell, New York
New York Medical College, Valhalla
University of Rochester Medical Center, Rochester
University of Pittsburgh Medical Center, Pittsburgh
Temple University Hospital, Philadelphia
Albert Einstein Medical Center, Division of Hepatology, Philadelphia
Washington Hospital Center, Washington D.C.
McGuire DVAMC, Richmond
Medical University of Southern Carolina, Charleston
Mayo Clinic Jacksonville, Jacksonville
University of Florida College of Medicine, Gainesville
University of Miami, Division of Hepatology / Center for Liver Disease, Miami
University of Alabama at Birmingham, Birmingham
University of Louisville, Louisville
Case Western Reserve / MetroHealth Medical Center, Cleveland
Cleveland Clinic Foundation, Cleveland
University of Cincinatti, Cincinnati
VA Medical Center / University of Iowa Hospital and Clinics, Iowa City
Northwestern University, Feinberg School of Medicine, Chicago
Rush University Medical Center, Chicago
Tulane University Health Sciences Center, New Orleans
Delta Research Partners, LLC, Monroe
Baylor University Medical Center, Dallas
Advanced Liver Therapies, St. Luke's Episcopal Hospital/Baylor College of Medicine, Houston
Permian Research Foundation, Odessa
University of Utah Health Sciences Center, Salt Lake City
Mayo Clinic Arizona, Phoenix
Scripps Clinic, San Diego
UCSD Medical Center, San Diego
UCSD Medical Center, La Jolla
UCSF - Fresno Community Regional Medical Center, Fresno
California Pacific Medical Center, San Francisco
Yale University School of Medicine, New Haven
Massachusetts General Hospital, Boston
Beth Israel Deaconnes Medical Center, Harvard Medical School, Boston
University of Massachusetts Memorial Medical Center, Worcester
Dartmouth Hitchcock Medical Center, Lebanon
UT Southwestern Medical Center, Dallas
Lead Sponsor
Ocera Therapeutics
INDUSTRY